Baltimore-Washington Financial Advisors’s Eli Lilly LLY Stock Holding History

Baltimore-Washington Financial Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.34M	Sell	2,539 -839	-25%	-$851K	0.1%	74
2025 Q4	$3.63M	Buy	3,378 +7	+0.2%	+$6.69K	0.15%	77
2025 Q3	$2.57M	Buy	3,371 +2,473	+275%	+$1.84M	0.11%	82
2025 Q2	$700K	Buy	898 +49	+6%	+$38.1K	0.03%	102
2025 Q1	$701K	Buy	849 +17	+2%	+$14.1K	0.04%	95
2024 Q4	$642K	Buy	832 +3	+0.4%	+$2.48K	0.03%	97
2024 Q3	$734K	Buy	829 +7	+0.9%	+$6.29K	0.04%	96
2024 Q2	$744K	Buy	+822	New	+$658K	0.04%	96
2024 Q1	–	Sell	-785	Closed	-$458K	–	140
2023 Q4	$458K	Sell	785 -95	-11%	-$55.5K	0.03%	109
2023 Q3	$473K	Buy	+880	New	+$453K	0.04%	109
2015 Q4	–	Sell	-200	Closed	-$16K	–	185
2015 Q3	$16K	Hold	200	–	–	0.01%	174
2015 Q2	$16K	Hold	200	–	–	﹤0.01%	169
2015 Q1	$15K	Hold	200	–	–	﹤0.01%	193
2014 Q4	$14K	Buy	+200	New	+$13.5K	﹤0.01%	192

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baltimore-Washington Financial Advisors's LLY Position: Q1 2026 in Review

Baltimore-Washington Financial Advisors reduced its Eli Lilly (LLY) stake by 25% in Q1 2026, selling an estimated $851K and leaving 2,539 shares worth $2.34M. The position accounts for 0.1% of the portfolio, ranked #74.

Baltimore-Washington Financial Advisors first reported a position in LLY in Q4 2014 and has held it in 14 quarters since. The position peaked at $3.63M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Baltimore-Washington Financial Advisors held 2,539 shares of Eli Lilly worth $2.34M as of Q1 2026.
Baltimore-Washington Financial Advisors sold 839 Eli Lilly shares in Q1 2026, an estimated $851K.
Eli Lilly made up 0.1% of Baltimore-Washington Financial Advisors's portfolio in Q1 2026, its #74 holding.
Baltimore-Washington Financial Advisors first reported a position in Eli Lilly in Q4 2014 and has held it in 14 quarters since.
Baltimore-Washington Financial Advisors's Eli Lilly position peaked at $3.63M in Q4 2025.
4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Baltimore-Washington Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.